Trials / Completed
CompletedNCT04793230
Nasolacrimal Sac Biopsy in Endoscopic Dacryocystorhinostomy
Predictive Value of Nasolacrimal Sac Biopsy in Endoscopic Dacryocystorhinostomy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
During dacryocystorhinostomy (DCR), the lacrimal sac wall biopsy is not routinely performed, but it is recommended if there is a suspicion of underlying disease other than preoperatively or intraoperatively chronic inflammation. We aimed to evaluate the utility of the histopathology examination of fifty patients in AlAzhar Hospitals to put recommendation for histopathology examination of such cases.
Detailed description
Most of patient with epiphora have different causes of nasolacrimal duct obstruction . This study aims to examine how important routine lacrimal sac biopsy is during endoscopic dacryocystorhinostomy surgery. The study included 50 patients with chronic unilateral epiphora. All patients underwent endoscopic dacryocystorhinostomy with nasolacrimal duct biopsy. Histopathologic analysis was performed for each specimen to assess the nature of the pathology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | biopsying | The procedure was carried out under general or local anesthesia. An otolaryngologist conducts the endoscopic intranasal operation, while an eye surgeon removes tissue from the sac and lacrimal tubes using lacrimal probes passed through the canaliculi. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2020-12-30
- Completion
- 2021-03-09
- First posted
- 2021-03-11
- Last updated
- 2021-03-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04793230. Inclusion in this directory is not an endorsement.